These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action. Salazar M; Lorente M; García-Taboada E; Hernández-Tiedra S; Davila D; Francis SE; Guzmán M; Kiss-Toth E; Velasco G Biochim Biophys Acta; 2013 Oct; 1831(10):1573-8. PubMed ID: 23567453 [TBL] [Abstract][Full Text] [Related]
28. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Oviedo A; Glowa J; Herkenham M Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305 [TBL] [Abstract][Full Text] [Related]
29. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys. Hruba L; Ginsburg BC; McMahon LR J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500 [TBL] [Abstract][Full Text] [Related]
30. Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Δ Hwang EK; Lupica CR Biol Psychiatry; 2020 Apr; 87(7):619-631. PubMed ID: 31543247 [TBL] [Abstract][Full Text] [Related]
31. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. Brents LK; Reichard EE; Zimmerman SM; Moran JH; Fantegrossi WE; Prather PL PLoS One; 2011; 6(7):e21917. PubMed ID: 21755008 [TBL] [Abstract][Full Text] [Related]
32. Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Balster RL; Prescott WR Neurosci Biobehav Rev; 1992; 16(1):55-62. PubMed ID: 1313164 [TBL] [Abstract][Full Text] [Related]
33. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis. Todd SM; Arnold JC Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899 [TBL] [Abstract][Full Text] [Related]
34. Activation of CB Joffre J; Yeh CC; Wong E; Thete M; Xu F; Zlatanova I; Lloyd E; Kobzik L; Legrand M; Hellman J J Immunol; 2020 Jun; 204(12):3339-3350. PubMed ID: 32385136 [No Abstract] [Full Text] [Related]
35. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons. Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227 [TBL] [Abstract][Full Text] [Related]
36. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Cooper ZD; Haney M Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504 [TBL] [Abstract][Full Text] [Related]
37. Palmer RHC; McGeary JE; Knopik VS; Bidwell LC; Metrik JM Am J Drug Alcohol Abuse; 2019; 45(5):514-526. PubMed ID: 31184938 [No Abstract] [Full Text] [Related]
38. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders. Krebs MO; Kebir O; Jay TM Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421 [TBL] [Abstract][Full Text] [Related]
39. Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. Xiong W; Cheng K; Cui T; Godlewski G; Rice KC; Xu Y; Zhang L Nat Chem Biol; 2011 May; 7(5):296-303. PubMed ID: 21460829 [TBL] [Abstract][Full Text] [Related]
40. Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans. D'Souza DC; Fridberg DJ; Skosnik PD; Williams A; Roach B; Singh N; Carbuto M; Elander J; Schnakenberg A; Pittman B; Sewell RA; Ranganathan M; Mathalon D Neuropsychopharmacology; 2012 Jun; 37(7):1632-46. PubMed ID: 22334121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]